http://stockcharts.com/h-sc/ui?s=COR&p=D&b=5&g=0&id=p88808768812&a=88732778 Money flow was strong on friday, nice reverse head and shoulders formation in the making. I think the DNA transaction is another example of both the US dollar weakness prompting consolidation from overseas but more importantly, a great innovator ( who also licenced a ton of it's technology from smaller biotechs) is off the radar and the money will have to go somewhere-both private investment capital and corporate R&D, though DNA will still hunt around for oncology R&D....i'D THINK.